Search Results 651-660 of 18490 for Prednisone

  1. A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients - Mayo Clinic

    prednisone or equivalent), androgens, or androgen reducing agents, systemic beta agonists or beta blockers, and relevant herbal, or nutraceutical products ...

  2. Nivolumab and Brentuximab Vedotin After Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Classical Hodgkin Lymphoma - Mayo Clinic

    Adrenal replacement doses > 10 mg daily prednisone equivalents in the absence of active autoimmune disease. Uncontrolled illness including ongoing or active ...

  3. ARrest RESpiraTory Failure From PNEUMONIA - Mayo Clinic

    A condition requiring inhaled corticosteroids or beta-agonists, or chronic systemic steroid therapy equivalent to a dose >10 mg prednisone (this does not ...

  4. Bendamustine Hydrochloride and Rituximab with or without Bortezomib Followed by Rituximab with or without Lenalidomide in Treating Patients with High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma - Mayo Clinic

    Prednisone or other corticosteroids used for non-lymphomatous conditions will not be considered as prior chemotherapy; A prior/recent short course (< 2 weeks) ...

  5. Staph infections - Diagnosis & treatment - Mayo Clinic

    A staph infection is diagnosed by finding the bacteria in pus, tissue samples, or body fluids, including blood and urine. For skin damage, your healthcare ...

  6. Chronocort Versus Standard Hydrocortisone Replacement Therapy to Treat Congenital Adrenal Hyperplasia in Participants Aged 16 Years and Over - Mayo Clinic

    A4 and currently treated with hydrocortisone, prednisone, prednisolone or dexamethasone (or a combination of the aforementioned glucocorticoids) and on ...

  7. A Study Of Andecaliximab In Participants With Fibrodysplasia Ossificans Progressiva (FOP) - Mayo Clinic

    Systemic corticosteroids with a prednisone equivalent of >10mg/day within 1 week of Study Day 1. If the participant requires chronic use of >10mg/day ...

  8. A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) - Mayo Clinic

    If using oral corticosteroids, must be on a stable dose equivalent to less than or equal to 10 mg/day of prednisone for at least 2 weeks prior to the first ...

  9. A Study of the Outcomes of Natalizumab plus Standard Steroid Treatment for High Risk Acute Graft-Versus-Host Disease - Mayo Clinic

    No prior systemic treatment for acute GVHD except for a maximum of 3 days of prednisone (or IV methylprednisolone) ≤2 mg/kg/day. Topical skin steroid ...

  10. An Open-label Study to Investigate the Efficacy, Safety and Tolerability of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy - Mayo Clinic

    ... prednisone-equivalent for > 14 days, within 6 months of screening. Note: Subjects required to take or who have taken a dose of ≤ 10 mg/day prednisone ...